163 related articles for article (PubMed ID: 17112623)
1. In the new area of noninvasive markers of hepatocellular carcinoma.
Paradis V; Bedossa P
J Hepatol; 2007 Jan; 46(1):9-11. PubMed ID: 17112623
[No Abstract] [Full Text] [Related]
2. A concise review of serum markers for hepatocellular cancer.
Wright LM; Kreikemeier JT; Fimmel CJ
Cancer Detect Prev; 2007; 31(1):35-44. PubMed ID: 17293059
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum cytokeratin-19 fragment (CYFRA 21-1) in hepatocellular carcinoma.
Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Ono K; Kubo S
J Hepatobiliary Pancreat Surg; 2006; 13(3):239-44. PubMed ID: 16708302
[TBL] [Abstract][Full Text] [Related]
4. Alpha-2 macroglobulin: an additional marker for diagnosis of hepatocellular carcinoma.
Kar P; Gandhi BM; Irshad M; Gupta H; Tandon BN
J Assoc Physicians India; 1987 Apr; 35(4):288-9. PubMed ID: 2443479
[No Abstract] [Full Text] [Related]
5. Hepatoma-related gamma-glutamyl transferase in laboratory or clinical diagnosis of hepatocellular carcinoma.
Yao DF; Dong ZZ
Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):9-11. PubMed ID: 17287158
[No Abstract] [Full Text] [Related]
6. [Molecular markers for early diagnosis of hepatocellular carcinoma].
Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213
[No Abstract] [Full Text] [Related]
7. The copper/zinc ratio in patients with hepatocellular carcinoma.
Ebara M; Fukuda H; Saisho H
J Gastroenterol; 2003; 38(1):104-5. PubMed ID: 12560932
[No Abstract] [Full Text] [Related]
8. Serum golgi phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
Li X; Wu K; Fan D
Hepatology; 2009 Nov; 50(5):1682. PubMed ID: 19739256
[No Abstract] [Full Text] [Related]
9. [Screening of serum biomarkers in hepatocellular carcinoma by SELDI technique: a preliminary study].
Yao DK; Zhu L; Wang WJ; Song ST
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):298-9. PubMed ID: 17456321
[No Abstract] [Full Text] [Related]
10. [Amplification of peripheral blood insulin-like growth factor II-mRNA and its clinical significance in the diagnosis of hepatocellular carcinoma].
Yao DF; Dong ZZ; Liu YH; Zhao L; Huang JF; Meng XY
Zhonghua Gan Zang Bing Za Zhi; 2003 Nov; 11(11):695-6. PubMed ID: 14636457
[No Abstract] [Full Text] [Related]
11. [Tumor markers and primary cancer of the liver].
Ballesta AM; Molina R
Med Clin (Barc); 1989 Sep; 93(7):256-8. PubMed ID: 2554076
[No Abstract] [Full Text] [Related]
12. Alpha-fetoprotein and hepatocellular carcinoma.
Colli A; Fraquelli M; Conte D
Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
[No Abstract] [Full Text] [Related]
13. Antithrombin III and hepatocellular carcinoma.
Lefrère JJ; Conard J; Lerable J; Samama M
Thromb Haemost; 1989 Sep; 62(2):817. PubMed ID: 2554522
[No Abstract] [Full Text] [Related]
14. Glypican-3 as a serum marker for hepatocellular carcinoma.
Capurro M; Filmus J
Cancer Res; 2005 Jan; 65(1):372; author reply 372-3. PubMed ID: 15665316
[No Abstract] [Full Text] [Related]
15. Biomarkers for the early detection of cancer: an inflammatory concept.
Roy HK; Khandekar JD
Arch Intern Med; 2007 Sep; 167(17):1822-4. PubMed ID: 17893302
[No Abstract] [Full Text] [Related]
16. Significance of RCAS1 antigen in hepatocellular, cholangiocellular and pancreatic carcinomas.
Enjoji M; Nakashima M; Yamaguchi K; Kotoh K; Nakamuta M
J Gastroenterol Hepatol; 2005 Aug; 20(8):1143-8. PubMed ID: 16048560
[TBL] [Abstract][Full Text] [Related]
17. Ratio of serum ornithine carbamoyltransferase to alanine aminotransferase as a potent indicator for hepatocellular carcinoma.
Murayama H; Fukuda Y; Tsunekawa S; Ikemoto M; Nagata A
Clin Biochem; 2007 Sep; 40(13-14):1077-80. PubMed ID: 17570354
[TBL] [Abstract][Full Text] [Related]
18. [Biochemical markers in the neoplasms of the liver, biliary tract and pancreas].
Higashino K; Sumikawa K
Nihon Rinsho; 1982; 40(1):43-50. PubMed ID: 6177881
[No Abstract] [Full Text] [Related]
19. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
[TBL] [Abstract][Full Text] [Related]
20. [The application of serum tumor markers in the diagnosis of hepatocellular carcinoma].
Liao HY
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):379-80. PubMed ID: 15918977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
